Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Telli Health Delivers World’s First 4G Cellular-Connected SpO2 Pulse Oximeter for COVID-19 Patients

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sutter Health and Allina Health Sign...

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to...

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following...

US-based medical device company Artivion has completed its acquisition...

Telli Health announced the delivery of the first FDA certified and approved 4G cellular-connected SpO2 pulse oximeter, addressing the unprecedented demand seen during the pandemic for remote patient monitoring (RPM) devices, particularly SpO2 pulse oximeter, to track COVID-19 patients.

The pulse oximeter rounds out Telli Health’s complete 4G package to measure and detect common physiological parameters. These devices also include a touchless thermometer, blood pressure monitor, blood glucometer, and weight scale, and serve as a complete COVID-19 kit to monitor pre- and post-discharged patients without any additional equipment required. Patient data is automatically transmitted directly into their existing health record and are available to their provider immediately, all from the comfort and safety of their home.

Telli Health’s Cellular SpO2 pulse oximeter, along with its other RPM devices, are valuable as an alternative to COVID-19 hospital admissions – they help reduce the spread of the virus and help free up hospital space for other emergencies, altogether improving healthcare delivery.

Telli Health Director of Product Support Alvaro Salgado, commented, “The pulse oximeter is the main device used to monitor COVID patients, so I am thrilled that our 4G cellular-connected SpO2 pulse oximeter is now being delivered to providers – Telli Health is responding to that demand. Providers have reported in the past that COVID patients indicated that they were feeling fine, when oxygen saturation levels were quite low. Our cellular-connected SpO2 pulse oximeter will alert providers of a problem and give them ample time to act accordingly. Our pulse oximeter is also significantly advantageous for its ease of use and low power requirements. This revolutionary technology will allow patients to remain at their hospital-in-home to recover in a familiar place in lieu of a traditional hospital room.”

Telli Health devices use SIM technology that connects to all major carriers including Verizon, AT&T, T-Mobile/ Sprint, providing a solution to patients in the most rural and remote areas, improving accessibility and allowing more patients to be reached.

Telli Health is the industry leader in medical IoT devices. Removing barriers and making medical devices easier to use and more accurate is Telli Health’s number one priority. Telli Health is proud to partner with the best network providers across the globe to deliver fast and reliable coverage for the best user experience possible, no matter the location.

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Sutter Health and Allina Health Sign Definitive Agreement to Join Forces

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to Build the Largest Pan-Asian Healthcare Investment Platform

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to Transform Healthcare

The National Health Service is moving forward with plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »